Pfizer and BioNTech Announce Phase 3 Trial Data Showing High …
WEBOct 21, 2021 — NEW YORK & MAINZ, Germany-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more than 10,000 individuals 16 …
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBAug 23, 2021 — The Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to: prevent COVID-19 in individuals 12 years of age and older, and; provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron …
WEBSep 20, 2024 — NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization for the companies’ Omicron KP.2-adapted monovalent COVID-19 vaccine (COMIRNATY ® KP.2) for active ...
FDA Approves First COVID-19 Vaccine
WEBFDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron …
WEB6 days ago — NEW YORK & MAINZ, Germany, September 20, 2024--Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use ...
US FDA authorizes Pfizer-BioNTech and Moderna's updated …
WEBSept 11 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID-19 vaccines from Pfizer (PFE.N) /BioNTech (22UAy.DE) and Moderna (MRNA.O) that target a...
‘Incredible milestone for science.' Pfizer and BioNTech update
WEBNov 18, 2020 — Pfizer and BioNTech update their promising COVID-19 vaccine result. Efficacy trial reaches endpoint and companies plan to soon submit data for emergency use authorizations in the United States and elsewhere. 18 Nov 2020. By Jon Cohen.
Pfizer and BioNTech Announce Vaccine Candidate Against …
WEBNov 9, 2020 — This release contains forward-looking information about Pfizer’s efforts to combat COVID-19, the collaboration between BioNTech and Pfizer to develop a potential COVID-19 vaccine, the BNT162 mRNA vaccine program, and modRNA candidate BNT162b2 (including qualitative assessments of available data, potential benefits, expectations for clinical ...
Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech …
WEBThe FDA has determined that Pfizer-BioNTech COVID-19 Vaccine has met the statutory criteria to amend the EUA, and that the known and potential benefits of this vaccine in individuals 12...
FDA Approves Pfizer Vaccine: Live Updates - The New York Times
WEBAug 23, 2021 — The Food and Drug Administration on Monday granted full approval to Pfizer-BioNTech’s coronavirus vaccine for people 16 and older, making it the first to move beyond emergency-use status in...
- Some results have been removed